Winkler Lori 4

What Happened
Lori Winkler, SVP and Chief Human Resources Officer of Zimmer Biomet (ZBH), received an award of 3,935 restricted stock units (RSUs) reported on Form 4. The filing shows an acquisition of 3,935 derivative RSUs at a reported price of $0.00 (awarded; no cash paid). These RSUs were performance-based awards granted originally on March 6, 2023, determined to be earned based on 2023–2025 performance and will vest on March 6, 2026.

Key Details

• Transaction date: February 19, 2026 (Period of Report); Form 4 filed February 23, 2026.
• Transaction type/code: Award/Grant (A); security = performance-based RSUs (derivative).
• Amount: 3,935 RSUs; reported acquisition price = $0.00 (reported value $0 on Form 4).
• Vesting: These RSUs were earned as of Feb 19, 2026 and are scheduled to vest on March 6, 2026.
• Footnotes: F1 — each RSU = contingent right to one share of common stock. F2 — RSUs were part of a March 6, 2023 grant tied to 2023–2025 performance; number earned was finalized Feb 19, 2026.
• Shares owned after transaction: not specified in the provided filing summary.
• Timeliness: Filed within required Form 4 window (filed Feb 23 for a Feb 19 transaction), so not late.

Context
RSUs are a form of compensation — a contingent right to receive company shares at vesting — so this is a compensation award rather than an open-market purchase or sale. Performance-based RSUs depend on company metric outcomes; once vested, they typically convert to shares (and may be subject to tax withholding). This filing documents the award and vesting schedule, not a cash transaction or immediate sale.